{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:01:32Z","timestamp":1779145292838,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13181-019-00735-w","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T06:18:35Z","timestamp":1567232315000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-6671","authenticated-orcid":false,"given":"Joseph","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian Patrick","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhshant","family":"Atti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim P.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"735_CR1","unstructured":"Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics; 2018."},{"key":"735_CR2","unstructured":"Kochanek K, Muprhy S, Xu J, Arias E. Mortality in the United States, 2016 National Center for Health Statistics; 2017."},{"issue":"33","key":"735_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.15585\/mmwr.mm6533a3","volume":"65","author":"AB Peterson","year":"2016","unstructured":"Peterson AB, Gladden RM, Delcher C, Spies E, Garcia-Williams A, Wang Y, et al. Increases in fentanyl-related overdose deaths\u2014Florida and Ohio, 2013-2015. MMWR Morb Mortal Wkly Rep. 2016;65(33):844\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"735_CR4","unstructured":"CDC Health Alert Network. Increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. 2015. \nhttps:\/\/emergency.cdc.gov\/han\/han00384.asp\n\n. Accessed 10 Apr 2019."},{"key":"735_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"R Rudd","year":"2016","unstructured":"Rudd R, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65:1445\u201352.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"735_CR6","unstructured":"Hedegaard H, Warner M, Mini\u00f1o AM. Drug overdose deaths in the United States, 1999\u20132017: National Center for Health Statistics; 2018."},{"issue":"6","key":"735_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.annemergmed.2014.07.017","volume":"64","author":"JM Stogner","year":"2014","unstructured":"Stogner JM. The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl disguised as other opioids. Ann Emerg Med. 2014;64(6):637\u20139.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"735_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1553-2712.1998.tb02707.x","volume":"5","author":"K Wanger","year":"1998","unstructured":"Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med. 1998;5(4):293\u20139.","journal-title":"Acad Emerg Med"},{"issue":"4","key":"735_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/10903120903144866","volume":"13","author":"TM Robertson","year":"2009","unstructured":"Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009;13(4):512\u20135.","journal-title":"Prehosp Emerg Care"},{"issue":"6","key":"735_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/15563650701877374","volume":"46","author":"H Schumann","year":"2008","unstructured":"Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol. 2008;46(6):501\u20136.","journal-title":"Clin Toxicol"},{"issue":"14","key":"735_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","volume":"66","author":"NJ Somerville","year":"2017","unstructured":"Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, et al. Characteristics of fentanyl overdose\u2014Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"735_CR12","doi-asserted-by":"publisher","first-page":"1):1","DOI":"10.1016\/j.annemergmed.2018.01.054","volume":"72","author":"FX Scheuermeyer","year":"2018","unstructured":"Scheuermeyer FX, DeWitt C, Christenson J, Grunau B, Kestler A, Grafstein E, et al. Safety of a brief emergency department observation protocol for patients with presumed fentanyl overdose. Ann Emerg Med. 2018;72:1):1\u20138. e1.","journal-title":"Ann Emerg Med"},{"issue":"11","key":"735_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.5694\/j.1326-5377.2008.tb01825.x","volume":"188","author":"MA Cretikos","year":"2008","unstructured":"Cretikos MA, Bellomo R, Hillman K, Chen J, Finfer S, Flabouris A. Respiratory rate: the neglected vital sign. Med J Aust. 2008;188(11):657\u20139.","journal-title":"Med J Aust"},{"issue":"5919","key":"735_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/bmj.2.5919.589","volume":"2","author":"J Evans","year":"1974","unstructured":"Evans J, Hogg M, Lunn J, Rosen M. Degree and duration of reversal by naloxone of effects of morphine in conscious subjects. Br Med J. 1974;2(5919):589\u201391.","journal-title":"Br Med J"},{"issue":"3","key":"735_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/add.14033","volume":"113","author":"R McDonald","year":"2018","unstructured":"McDonald R, Lorch U, Woodward J, Bosse B, Dooner H, Mundin G, et al. Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: phase I healthy volunteer study. Addiction. 2018;113(3):484\u201393.","journal-title":"Addiction."},{"key":"735_CR16","unstructured":"Food and Drug Administration. Prescribing information for naloxone nasal spray. \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/208411lbl.pdf\n\n. Accessed 10 Apr 2019."},{"key":"735_CR17","unstructured":"Immunalysis Corporation. Fentanyl urine HEIA drug screening kit. \nhttps:\/\/immunalysis.com\/wp-content\/uploads\/2016\/10\/Fentanyl_HEIA_MKT50368_2.pdf\n\n. Accessed 10 Apr 2019."},{"issue":"2","key":"735_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra1202561","volume":"367","author":"EW Boyer","year":"2012","unstructured":"Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146\u201355.","journal-title":"N Engl J Med"},{"issue":"4","key":"735_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/15563659609013811","volume":"34","author":"JJ Osterwalder","year":"1996","unstructured":"Osterwalder JJ. Naloxone\u2014for intoxications with intravenous heroin and heroin mixtures-harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol. 1996;34(4):409\u201316.","journal-title":"J Toxicol Clin Toxicol"},{"key":"735_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","volume":"46","author":"JJ Carroll","year":"2017","unstructured":"Carroll JJ, Marshall BD, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136\u201345.","journal-title":"Int J Drug Policy"},{"key":"735_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and-substituted \u2018heroin\u2019. Int J Drug Policy. 2017;46:146\u201355.","journal-title":"Int J Drug Policy"},{"key":"735_CR22","unstructured":"National Institute on Drug Abuse. Opioid overdose reversal with naloxone (Narcan, Evzio). \nhttps:\/\/www.drugabuse.gov\/related-topics\/opioid-overdose-reversal-naloxone-narcan-evzio\n\n. Accessed 10 Apr 2019."},{"key":"735_CR23","unstructured":"Harm Reduction Coalition. Guide to developing and managing overdose prevention and take-home naloxone projects. 2012."},{"issue":"10","key":"735_CR24","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/j.1360-0443.2008.02314.x","volume":"103","author":"J Strang","year":"2008","unstructured":"Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103(10):1648\u201357.","journal-title":"Addiction."},{"issue":"3","key":"735_CR25","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199303000-00030","volume":"76","author":"JH Silverstein","year":"1993","unstructured":"Silverstein JH, Rieders MF, McMullin M, Schulman S, Zahl K. An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesth Analg. 1993;76(3):618-21.","journal-title":"Anesth Analg"},{"issue":"6","key":"735_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/17843286.2000.11754319","volume":"55","author":"M Vandevenne","year":"2000","unstructured":"Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg. 2000;55(6):323\u201333.","journal-title":"Acta Clin Belg"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00735-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:52:59Z","timestamp":1598658779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00735-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00735-w","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"19 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}